In situ neoplasms

No definition available.

Endpoint definition

Summary Statistics

Key figures

All Female Male
Number of individuals 4197 2918 1279
Unadjusted prevalence (%) 1.61 1.99 1.13
Mean age at first event (years) 63.68 60.39 71.20

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.69 [1.99, 3.64] 1.1e-10 431
15 years 0.02 3.11 [2.42, 4.00] 1.1e-18 405
5 years 0.00 3.93 [3.08, 5.01] 4.6e-28 222
1 year - - - -

Correlations

Index endpoint: CD2_INSITU – In situ neoplasms
GWS hits: 3

Survival analyses between endpoints

Plot

before In situ neoplasms
after In situ neoplasms

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after In situ neoplasms